Summary

Overview
Global Pigmented Lesion Treatment Market reached US$ XX billion in 2022 and is expected to reach US$ XX million by 2030 growing at a CAGR of XX% during the forecast period 2023-2030.
Pigmented lesion treatment refers to the various medical and aesthetic procedures designed to address abnormal pigmentation on the skin. Pigmentation in the skin is primarily determined by the presence and distribution of melanin, the pigment responsible for skin, hair, and eye color. Pigmented lesions can manifest as darker or lighter areas on the skin.
Pigmented lesions often involve melanin that results in small or large areas of the skin appearing brown, black, or even blue. Pigmented skin lesions are most often melanocytic. However, non-melanocytic lesions can also be pigmented, particularly in dark-skinned individuals.
Market Dynamics
Increasing product launches
The increasing product launches for pigmented lesion treatment act as a significant driver for market growth. Pigmented lesions can include areas of hyperpigmentation or hypopigmentation and can result from conditions such as sun damage, age spots, freckles, birthmarks, melasma, and certain types of skin lesions.
For instance, in November 2023, Justera Health Ltd. launched an extended range of premium laser treatment services with CUTERA XEO. XEO is a premium laser platform designed for skin revitalization and resurfacing, pigmented lesions, vascular lesions, and hair removal.
Additionally, in July 2023, DEKA, a subsidiary of the El.En. Group launch of its new “PRO” line, based on laser and microwave devices. It is also strongly optimized for vascular treatments, superficial pigmented lesions, and skin rejuvenation.
Also, in June 2022, Cynosure launched the PicoSure Pro device for safe and effective treatments for unwanted pigmentation and skin revitalization for all skin types. The PicoSure Pro device can uniquely deliver 755nm energy in picoseconds.
Furthermore, significant growth drivers such as the rising prevalence of pigmentation disorders, and technological advancements in treatment devices are expected to drive the market in the forecast period.
Side effects associated with laser treatments
Laser treatment helps in skin resurfacing and pigmentation reduction. In some cases, a person can experience changes to the pigmentation of the treated area, including the darkening or lightening of the area. Also, some individuals can experience bruising, especially after more aggressive laser treatments.
Segment Analysis
The global pigmented lesion treatment market is segmented based on lesion type, product type, end user and region.
The lasers and energy based devices segment accounted for approximately 62.5% of the market share
The lasers and energy-based devices segment is expected to hold the largest market share over the period forecast due to the increasing number of product approvals. Lasers and energy-based devices are widely used in dermatology and cosmetic procedures for various skin treatments. RF energy is used to heat the skin's deeper layers, promoting collagen remodeling and improving skin tightness.
For instance, in 2022, LASEROPTEK Co., Ltd. received U.S. Food and Drug Administration 510(k) clearance for its HELIOS IV-785 laser system for use in dermatology and general surgery. It is used to treat skin toning, brightening, benign pigmented and vascular lesion removal, and multi-color tattoo eradication.
Additionally, in March 2023, The US Food and Drug Administration (FDA) cleared Candela Corporation’s PicoWay laser for the treatment of café au lait, lentigines, and melasma. the laser system has been approved for several indications, including acne scarring, benign pigmented lesions, tattoo removal, and wrinkles. Hence, due to the above factors, the segment is expected to hold the largest market share.
Geographical Analysis
North America is expected to hold a significant position in the global pigmented lesion treatment market share
The global pigmented lesion treatment market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.
North America has maintained a significant market proportion due to factors such as the rising aesthetic surgical procedures, increasing prevalence of pigmentation disorders, and increasing healthcare expenditure, this trend is anticipated to continue throughout the forecast period.
For instance, according to the Aesthetics Society, aesthetic surgical procedures increased 54% and non-surgical procedures were up 44%. The average plastic surgeon performed 320 surgical procedures in 2021 in the United States.
Additionally, according to the National Institute of Health, the population-based prevalence estimate of overall vitiligo in adults is between 0.76% (1.9 million cases) and 1.11% (2.8 million cases). Also, the study suggests that approximately 40% of adult vitiligo in the U.S. may be undiagnosed.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the global pigmented lesion treatment market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatment, drug launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the pigmented lesion treatment market is expected to be moderately affected over the forecast period.
Market Segmentation
By Lesion Type
• Freckles
• Lentigines
• Melasma
• Others
By Product Type
• Lasers and Energy Based Devices
• RF Devices
• Ultrasound Devices
• Others
By End User
• Dermatology Clinics
• Hospitals
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Alma Lasers Ltd, Cutera Inc., Cynosure Inc., Lumenis Be Ltd., Lutronic Corporation, Lynton Lasers Ltd, Bausch Health, Fotona, Asclepion Laser Technologies, Candela Corporation among others.
Key Developments
• In April 2021, Cynosure acquired the MyEllevate Surgical Suture System, expanding the Company's portfolio of minimally invasive facial rejuvenation solutions.
Why Purchase the Report?
• To visualize the global pigmented lesion treatment market segmentation based on lesion type, product type, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global pigmented lesion treatment market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global pigmented lesion treatment market report would provide approximately 58 tables, 58 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Lesion Type
3.2. Snippet by Product Type
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing product launches
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Side effects associated with laser treatments
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Lesion Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
7.1.2. Market Attractiveness Index, By Lesion Type
7.2. Freckles*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Lentigines
7.4. Melasma
7.5. Others
8. By Product Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.1.2. Market Attractiveness Index, By Product Type
8.2. Lasers and Energy Based Devices*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. RF Devices
8.4. Ultrasound Devices
8.5. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Dermatology Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hospitals
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Lesion Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Alma Lasers Ltd.
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Cutera Inc.
12.3. Cynosure Inc.
12.4. Lumenis Be Ltd.
12.5. Lutronic Corporation
12.6. Lynton Lasers Ltd
12.7. Bausch Health
12.8. Fotona
12.9. Asclepion Laser Technologies
12.10. Candela Corporation
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us